BMO Capital Maintains Their Buy Rating on CareTrust REIT (CTRE)

By Carrie Williams

In a report released today, John Kim from BMO Capital maintained a Buy rating on CareTrust REIT (CTREResearch Report), with a price target of $22. The company’s shares closed yesterday at $22.03, close to its 52-week high of $22.66.

According to TipRanks.com, Kim is a 4-star analyst with an average return of 4.8% and a 59.8% success rate. Kim covers the Financial sector, focusing on stocks such as Apartment Investment & Management, Franklin Street Properties, and National Health Investors.

CareTrust REIT has an analyst consensus of Strong Buy, with a price target consensus of $22.33, implying a 1.4% upside from current levels. In a report issued on February 7, Raymond James also maintained a Buy rating on the stock with a $24 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $22.66 and a one-year low of $12.73. Currently, CareTrust REIT has an average volume of 985.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CareTrust REIT, Inc. is a real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in San Clemente, CA.